Searched for
ENDO PHARMA
Smallcap pharma stock jumps over 11% as arm receives tentative USFDA approval for HIV drug DolutegravirThe company has 260 cumulative ANDA filings (including the recently acquired portfolio from Endo at Chestnut Ridge) with the USFDA, of whic...- Buy Strides Pharma Science, target price Rs 402: ICICI SecuritiesStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 3026.83 Crore) operating in Pha...
- Strides' founder Arun Kumar back to helm the company"The Board of Directors of the Company (Board) accepted Ananth’s resignation and thanked him for his leadership, commitment, enthusiasm, an...
- Strides Pharma arm gets USFDA nod to market Amantadine Hydrochloride Softgel Capsules in AmericaStrides Pharma Global Pte Ltd Singapore has received approval from the US Food and Drug Administration (USFDA) for the medication, the comp...
- Strides Pharma banks on acquired Endo portfolio for turnaround of its US businessOn August 6, 2021, Strides announced acquisition of an Endo manufacturing facility in the US along with a basket of ANDAs for $24.9 million...
- Strides Pharma says could take 3-4 qtrs for normalcy of US business hit price erosionThe company on Wednesday reported a net loss of Rs 168 crore in Q2FY22. In the H1FY22, Strides accumulated a net loss of Rs 376.6. Revenues...
- Strides Pharma Science to acquire Endo's manufacturing facility in US along with basket of ANDAsStrides said the facility at Chestnut Ridge, New York has an annual capacity of 2 billion units across semi- solids, liquids, nasal sprays ...
- Alembic Pharma gets USFDA nod for anti-viral drugQuoting IQVIA data, Alembic Pharma said Amantadine Hydrochloride Tablets, 100 mg have an estimated market size of USD 13 million for twelve...
- Jubilant Pharma gets USFDA nod for Symmetrel's generic versionThe approved drug, generic version of Symmetrel of Endo, is indicated for the prophylaxis and treatment of signs and symptoms of infection ...
- US generics probe reveals startling detail of price fixing in Doxycycline and GlyburideA Bloomberg report said two executives of Heritage Pharma – the US arm of Indian drug maker Emcure - are preparing to plead guilty to price...
- US Justice Deptt charge against pharma cos a serious charge: Surajit Paul, Prabhudas Lilladher“In Sun-Taro’s case, they pushed up the price because there was not much competition or suppliers.”
- Sun Pharma arms get US subpoena over drugs pricingSun Pharma, India’s largest drug maker, has received a grand jury subpoena from the anti-trust division of the US Department of Justice see...
- US subsidiary of Sun Pharma gets sub poena from US Justice DepartmentTwo market analysts were of the view that the move may lead to a subdued sentimental outlook in the near term for Sun Pharma.
- Sun Pharma gets US subpoena over generic drugs pricingThe subpoena comes amid a wider probe by US regulators into steep increases in the prices of generic medicines in recent years.
- Aurobindo Pharma gets US Food and Drug Administration nod for two drugsThe drug is bio-equivalent and therapeutically equivalent to the reference listed product Pepcid AC Tablets -- 10 mg and 20 mg of McNeil Co...
- Glenmark Pharma gets final USFDA nod for migraine drugQuoting IMS data, Glenmark said the approved product has an estimated market size of $87.8 million for the 12 months ended January 2016.
- Teva’s hostile bid for Mylan: Deal could open up a $2-billion opportunity for pharma companiesAccording to experts, there is a possibility that the fruition of the deal will open up a $2-billion opportunity for Indian generic pharma ...
- Cipla plans to acquire US-based pharma cos; stock inches upSources indicated that Cipla is in talks to acquire companies with large manufacturing units in generics, respiratory and oncology spaces.
- Dr Reddy's, Sun Pharma among 14 firms probed by US Congress over drug price"When you see how much the prices of these drugs have increased just over the past year, it's staggering, and we want to know why," said Cu...
- Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA nod for asthma drugIndian drug makers are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and ...
Load More
